إعلان
إعلان
CHRS
Coherus Oncology, Inc. Common Stock
1.70
USDبرعاية
+0.17
+10.78%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
1.72
+0.02
+1.18%
تقارير أرباح CHRS
النسبة الإيجابية المفاجئة
CHRS تفوق 15 من 40 آخر التقديرات.
38%
التقرير التالي
بيانات التقرير القادم
٠٩ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$14.48M
/-$0.35
التغير الضمني من Q3 25 (Revenue/ EPS)
+25.12%
/+6.06%
التغير الضمني من Q4 24 (Revenue/ EPS)
-73.26%
/+25.00%
Coherus Oncology, Inc. Common Stock earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, CHRS reported earnings of -0.33 USD per share (EPS) for Q3 25, beating the estimate of -0.33 USD, resulting in a 0.45% surprise. Revenue reached 11.57 مليون, compared to an expected 13.68 مليون, with a -15.43% difference. The market reacted with a -10.07% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 المحللين forecast an EPS of -0.35 USD, with revenue projected to reach 14.48 مليون USD, implying an زيادة of 6.06% EPS, and زيادة of 25.12% in Revenue from the last quarter.
الأسئلة الشائعة
What were Coherus Oncology, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Coherus Oncology, Inc. Common Stock reported EPS of -$0.33, missing estimates by 0.45%, and revenue of $11.57M, -15.43% below expectations.
How did the market react to Coherus Oncology, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -10.07%, changed from $1.49 before the earnings release to $1.34 the day after.
When is Coherus Oncology, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٠٩ مارس ٢٠٢٦.
What are the forecasts for Coherus Oncology, Inc. Common Stock's next earnings report?
Based on 7
المحللين, Coherus Oncology, Inc. Common Stock is expected to report EPS of -$0.35 and revenue of $14.48M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان